Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Liposomal Bupivacaine TAPB Combined With Oxycodone PCIA on Postoperative Gastrointestinal Function in Patients Undergoing Major Abdominal Surgery: A Randomized Controlled Trial

NCT07651722 is registered in ClinicalTrials.gov with Tianjin First Central Hospital as lead sponsor.

NCT NCT07651722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07651722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Liposomal Bupivacaine TAPB Combined With Oxycodone PCIA on Postoperative Gastrointestinal Function in Patients Undergoing Major Abdominal Surgery: A Randomized Controlled Trial
Lead sponsor
Tianjin First Central Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
June 16, 2026
Completion date
September 30, 2026
Enrollment
132 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative ileus, postoperative pain